In 2026, medicine reaches a historic milestone: messenger RNA (mRNA) vaccines are no longer used solely to prevent infections. They now target cancer, with results that were still unimaginable five years ago. BioNTech, Moderna, and several European university research teams are announcing clinical trials with promising — even spectacular —...